Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2019-04-11 2019-04-11
Drug Identification Number 02440628 02440628
Brand name TEVA-PANTOPRAZOLE MAGNESIUM TEVA-PANTOPRAZOLE MAGNESIUM
Common or Proper name PANTOPRAZOLE MAGNESIUM PANTOPRAZOLE MAGNESIUM
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-07-15 2018-07-15
Estimated end date 2019-03-30 2019-03-30
Actual end date 2019-03-30 2019-03-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Product being allocated monthly but cannot support additional demand. Product being allocated monthly but cannot support additional demand.
Health Canada comments